Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety of Rifaximin for the Prevention of Travelers' Diarrhea in Subjects Traveling Outside the United States
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Traveller's diarrhoea
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Bausch Health Companies; Salix Pharmaceuticals